Please login or register first to view this content.
Oncology Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancer
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic cancer
- Head and neck cancer
- Kaposi’s sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
- Solid tumors
NEWS & FEATURES
Gabapentin May Cut Opioid Needs for Oral Mucositis Pain During RT
Mirvetuximab Soravtansine Granted Priority Review for Ovarian Cancer
Increased Flexibility Seen in Preapproval Evidence for New Drugs
Tasquinimod Gets Orphan Drug Designation for Myelofibrosis
Do Veterans Receive Lung Cancer Screening at Recommended Intervals?
Trial Evaluating Tiragolumab Combo in PD-L1 High NSCLC Misses PFS Endpoint
Colonoscopy Before Age 50 May Cut Colorectal Cancer Risk in Women
April 2022: Drug Pipeline Updates
April 2022: Notable Drug Approvals
Use of Proton Beam Therapy for Newly Diagnosed Cancer on the Rise
Enhertu Approval Broadens Breast Cancer Indication to Earlier Use
FDA Clears Automated, Wearable 3D Breast Ultrasound Device
Response to CAR-T Cell Therapy Similar for Minority Patients
Darolutamide Plus Docetaxel Gets Priority Review for Metastatic Hormone-Sensitive Prostate Cancer
Consider COVID Vax History When Assessing Adenopathy on Mammo
Enhertu Designated Breakthrough Therapy for HER2-Low Metastatic Breast Cancer
COVID-19 mRNA Vaccine Efficacy Wanes Over Time in RCC Cases
Combo Immunotherapy Gets Priority Review for Advanced Liver Cancer
